Table 2.

In vitro antibacterial and antifungal activity data of test compounds: 4-31

Minimum inhibitory concentration MIC (μg/mL)
Comp. code	S a	B.s	E.c	P.a	S.t	K.P	C.a	A.n
4	50	25	6.25	50	50	50	3.12	6.25
5	50	6.25	25	25	50	50	12.5	25
6	100	50	50	100	100	50	25	50
7	25	50	50	50	25	6.25	6.25	12.5
8	12.5	25	25	50	25	50	12.5	6.25
9	100	100	100	100	50	100	50	50
10	3.12	6.25	6.25	6.25	6.25	6.25	12.5	25
11	25	50	100	100	25	100	12.5	25
12	50	25	25	50	50	25	25	50
13	25	25	50	25	50	50	50	25
14	50	50	25	50	50	100	25	25
15	25	50	12.5	50	50	100	12.5	25
16	100	50	100	100	100	100	>100	>100
17	50	12.5	12.5	50	12.5	25	50	50
18	50	100	50	100	100	100	12.5	25
19	25	50	25	100	50	25	12.5	12.5
20	>100	>100	>100	>100	>100	>100	>100	>100
21	50	25	50	50	50	25	6.25	12.5
22	50	50	50	50	50	50	25	25
23	50	50	50	50	50	50	50	25
24	100	100	6.25	100	100	12.5	12.5	12.5
25	100	100	50	100	50	50	50	50
26	50	50	25	50	50	50	25	25
27	25	25	12.5	50	25	50	6.25	12.5
28	50	50	50	100	50	100	12.5	25
29	25	25	25	100	25	100	25	12.5
30	50	100	50	100	100	>100	25	12.5
31	>100	>100	>100	>100	>100	>100	>100	>100
*CIP.	0.78	0.78	0.78	0.78	0.78	0.78	-	-
*FLU.	-	-	-	-	-	-	12.5	12.5

S.a: Staphylococcus aureus, B.s:Bacillus subtilis, E.c:Escherichia coli, P.a: Pseudomonas aeruginosa, S.t: Salmonella typhi, K.p: Klebsiella pneumonia, C.a: Candida albicans, A.n: Aspergillus niger.

*CIP: Ciprofloxacin, *FLU: Fluconazole.

Experiments in duplicates.